Hong Kong stocks surge | Sinopharm Group-B (02257.HK) up more than 12% again, the company has received strategic equity investment from Huaxi Bio. Both parties will explore the possibility of business cooperation.

According to the Wise Finance and Economics APP, Sino Biopharmaceutical Limited-B (02257.HK) has risen by more than 12% again, with a cumulative increase of over 120% in the month. As of the time of writing, it is up 11.32% to 20.46 Hong Kong dollars, with a trading volume of 17.05 million Hong Kong dollars.